Ethylene Oxide Sterilization For Disposable Medical Products

Oct 22, 2026

Disposable medical products are widely used in hospitals, clinics, diagnostic laboratories, and surgical facilities. Items such as syringes, infusion sets, catheters, wound dressings, and respiratory accessories are often supplied in sterile packaging and intended for single use or one patient procedure.

Manufacturers must select a sterilization method that meets the product's intended use without compromising its physical properties, functional performance, or packaging integrity. Steam, radiation, and ethylene oxide (EtO) are among the sterilization technologies used for medical products. The appropriate method depends on product design, materials, manufacturing requirements, and validation results.

Ethylene oxide sterilization is particularly useful for selected disposable medical devices that are sensitive to heat or moisture, contain complex internal passages, or require sterilization within compatible packaging. The gas can penetrate certain packaging materials and reach accessible product surfaces that may be difficult to process using other methods.

However, EtO is not necessary for every disposable medical product. Manufacturers must assess product compatibility, sterilization effectiveness, residual chemicals, and regulatory requirements before establishing a production process.

The following product categories represent important applications for manufacturers evaluating an ethylene oxide sterilization system.

Catheters are among the well-established applications for EtO sterilization. These products may contain narrow lumens, flexible polymer components, connectors, and other structures that require careful process evaluation.

Examples include:

Urinary catheters

Intravenous catheters

Drainage catheters

Multi-lumen catheters

Selected disposable medical tubing assemblies

The main challenge is ensuring that the sterilization process reaches the required product surfaces. Lumen diameter, length, geometry, packaging, and load configuration can influence sterilant access.

Manufacturers should therefore evaluate the complete device and its packaging rather than assuming that all catheter designs can use the same sterilization cycle.

Disposable syringes and intravenous administration products are used to deliver fluids, administer medication, and connect patients to infusion systems.

Potential applications include disposable syringes, needle assemblies, IV infusion sets, extension tubing, and related medical fluid-delivery components.

Many of these products contain polymer parts and may be assembled from multiple components. EtO may be appropriate when the selected materials and product design are compatible with the process.

Important evaluation points include dimensional stability, connection integrity, packaging permeability, and the potential for materials to retain EtO. Manufacturers must also establish suitable aeration and residue-control procedures before releasing sterilized products.

Blood collection products and dialysis accessories may contain interconnected tubing, flexible materials, connectors, and fluid-contact surfaces.

Examples include blood collection sets, dialysis tubing sets, bloodlines, and selected disposable fluid-management assemblies.

For these products, manufacturers should consider the entire fluid pathway, component assembly, packaging configuration, and material compatibility. Sterilization must be validated for the intended product and load, including relevant internal surfaces.

Residual EtO is another important consideration because certain materials may absorb the gas during processing. Appropriate aeration and residue testing should form part of the validated manufacturing process.

Surgical procedure packs may combine several disposable components into one packaged unit. Depending on the application, these packs can contain cannulas, tubing, plastic instruments, dressings, and other surgical accessories.

Selected single-use surgical instruments and preassembled procedure kits may be suitable for EtO sterilization when their materials and configurations support the method.

The challenge is achieving consistent processing across the entire pack. Components can differ in shape, material, packaging position, and sterilant accessibility.

Before introducing a new kit or changing its contents, manufacturers should assess whether the existing validated process remains appropriate. Changes to packaging, component placement, or load density may require additional validation.

Wound care products include dressings and other materials designed to cover wounds, absorb fluids, or support clinical treatment.

Selected wound dressings, gauze products, and absorbent medical supplies may be sterilized using EtO, depending on their composition and intended use.

These products require careful consideration because absorbent materials can interact with the sterilant. The product's composition, packaging, exposure conditions, and aeration requirements all influence the final result.

Manufacturers should verify that the sterilization process achieves the required microbiological outcome while maintaining product performance and meeting applicable residue limits.

Respiratory and anesthesia products may contain flexible tubing, molded connectors, masks, seals, and other polymer components.

Potential applications include selected breathing circuits, anesthesia masks, respiratory tubing, and disposable ventilation accessories.

EtO may be considered when these products are incompatible with alternative sterilization methods or require processing in their assembled configuration. Product-specific compatibility testing remains necessary, particularly when several materials are combined.

For devices containing electronic or powered components, the entire assembly must be evaluated. Compatibility cannot be established solely from the properties of individual plastic parts.

The value of EtO sterilization comes from its ability to address specific product and manufacturing challenges.

Low-temperature processing: EtO can be used for selected products that cannot tolerate the temperatures associated with conventional steam sterilization. Actual operating conditions must be established for the product and validated process.

Penetration of compatible packaging: Certain packaging materials permit sterilant transfer while preserving the sterile barrier after processing. Packaging compatibility and sealing performance must be verified.

Access to complex structures: Catheters, multi-lumen tubing, and assembled products can present challenges for sterilant delivery. EtO may be suitable when the process has been validated for the relevant geometry and load.

Compatibility with selected materials: Some plastics, elastomers, and mixed-material assemblies may be suitable for EtO. Compatibility depends on the complete formulation, construction, and exposure conditions.

These characteristics explain why EtO remains important in medical device manufacturing. They do not eliminate the need to compare alternative technologies or conduct product-specific validation.

Before purchasing an EtO sterilizer, disposable medical product manufacturers should assess several technical variables.

Different polymers, rubber components, adhesives, coatings, and absorbent materials may respond differently to EtO exposure. Evaluation should address changes in dimensions, strength, flexibility, chemical properties, and functional performance where relevant.

Sterilization packaging must permit the required process while maintaining the sterile barrier. Packaging material, seal integrity, product placement, and the number of packaging layers can affect the result.

A chamber may accommodate a certain physical volume, but that does not automatically establish that every load configuration can be sterilized effectively. Product quantity, carton dimensions, packaging orientation, and spacing should be assessed during process development.

EtO can remain in some materials after the exposure phase. Aeration requirements depend on the product, material properties, packaging, and validated process.

ISO 10993-7 addresses the assessment of residual ethylene oxide and ethylene chlorohydrin in applicable medical devices. Manufacturers should establish and verify appropriate residue limits and release criteria.

ISO 11135 specifies requirements for developing, validating, and routinely controlling EtO sterilization processes for medical devices. Validation must demonstrate that the defined process can consistently achieve the required result for the intended product and load.

These requirements should be considered during equipment planning, not only after installation.

An appropriate ethylene oxide sterilizer should match the product range, production volume, facility layout, and process requirements.

Manufacturers should review the following factors before finalizing equipment specifications:

Chamber dimensions: Calculate the size and arrangement of the products, packaging, and loading equipment.

Production capacity: Define the batch quantity and required production schedule.

Process control: Review temperature, humidity, vacuum, exposure conditions, monitoring, alarms, and interlocks.

Gas distribution: Assess the equipment's ability to support the validated process throughout the intended load.

Aeration arrangements: Plan how sterilized products will be aerated and released according to established requirements.

Safety systems: Evaluate gas handling, leak detection, ventilation, exhaust treatment, and applicable environmental controls.

Qualification support: Establish the scope of installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ), as appropriate.

An equipment supplier should understand these requirements before proposing a chamber configuration. This helps reduce the risk of selecting equipment based only on capacity while overlooking the actual product and process constraints.

Riches Engineering Co., LTD provides engineering solutions for ethylene oxide sterilization equipment. For disposable medical product manufacturers, selecting an appropriate system begins with a review of the products, materials, packaging, batch requirements, and available installation space.

Riches supports equipment projects through several engineering activities.

Customized equipment design: Equipment requirements can be evaluated against chamber dimensions, load arrangements, production needs, and facility conditions.

3D design before manufacturing: Three-dimensional design allows customers to review equipment placement and spatial requirements before fabrication, helping identify potential installation constraints early.

Installation and commissioning: Project support can include equipment installation and commissioning based on the agreed engineering scope.

IQ/OQ/PQ-related support: Qualification activities can be incorporated into the project plan to support verification of installation, operational functions, and equipment performance under defined conditions. Product-specific sterilization validation remains the manufacturer's responsibility within its quality system and applicable regulatory framework.

For projects involving catheters, disposable syringes, IV sets, surgical kits, or wound dressings, customers should provide product dimensions, material specifications, packaging details, expected batch quantities, and relevant process requirements.

This information helps Riches evaluate the proposed equipment configuration and identify the technical issues that require further review.

Planning a disposable medical product sterilization project? Contact Riches to discuss your product applications, chamber requirements, equipment customization, and installation conditions.

Potential applications include catheters, syringes, IV sets, selected surgical instruments, procedure packs, wound dressings, and certain respiratory consumables. The appropriate method depends on the product and its validated sterilization requirements.

No. Different polymers, additives, adhesives, and product designs respond differently to sterilization. Manufacturers must evaluate compatibility and validate the process for each relevant product configuration.

Some products absorb or retain EtO during processing. Aeration helps reduce residual levels, but the required conditions and release criteria must be established and verified for the specific product.

Important information includes product dimensions, material composition, packaging design, batch quantity, production schedule, facility layout, and validated process requirements.

Riches supports customized EtO sterilizer projects through engineering design, 3D design before manufacturing, installation, commissioning, and qualification-related support according to the project scope.

Ethylene oxide sterilization is an important option for selected disposable medical products that require low-temperature processing or present challenges related to materials, packaging, and complex structures.

Catheters, syringes, infusion sets, blood collection products, wound dressings, respiratory consumables, and surgical procedure packs represent key application categories. However, the appropriate sterilization method must be determined through product-specific assessment and validated processing requirements.

For manufacturers planning a new production line or upgrading existing sterilization capacity, equipment selection should account for product geometry, chamber configuration, process control, aeration, safety systems, and qualification requirements.

Riches provides engineering support for customized EtO sterilization equipment projects, helping customers evaluate equipment configuration and facility requirements before manufacturing and installation.

EO Sterilization For Plastic Medical Devices And Catheters

What Medical Devices Can Be Sterilized With Ethylene Oxide?